Furthermore, previous research has shown that the RFC4 expression level may serve as a prognostic indicator for the efficacy of radiation and the overall prognosis of neoadjuvant radiation therapy in individuals diagnosed with locally advanced rectal cancer [17]. The gene discussed is RFC4; the disease is rectal cancer.